Skip to main content

Advertisement

SpringerLink
Log in

Immunosuppression in murine renal cell carcinoma

II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

In our companion paper we have reported that cell-mediated immunity of mice bearing renal cell carcinoma is profoundly suppressed. The non-responsiveness of such animals was found to be attributable to Renca cells themselves and to splenic lymphoid cells that down-regulate other fully capable lymphoid cells. In this communication the lymphoid cell source of suppression within Rencabearing mice has been explored with the aim of identifying phenotypes of the responsible cells, the manner by which suppression is mediated, and initial ways by which suppression may be eliminated. A plastic-adherent cell bearing the Thy 1.2 surface marker as well as the Lyt1 and Lyt2 antigens has been found to operate, perhaps in conjunction with macrophages, to down-regulate lymphokine-activated killer (LAK) cell development for natural killer (NK) and non-NK targets that include Renca cells themselves. The splenic suppressor cells lost the capacity to suppress the NK response of normal recipient mice upon shallow irradiation (250 rad) prior to adoptive transfer. Spleen cells, presumably macrophages, from Renca-bearing mice were found to suppress the generation of LAK and NK cellsin vitro by synthesizing prostaglandins. Indomethacin, a prostaglandin synthetase inhibitor, blocked the induction of suppression bothin vitro andin vivo, suggesting the presence of endogenous prostaglandins in Renca-bearing mice. The suppression seen in Renca-bearing mice that derives from multiple sources and has been prevented by two separate methods has been discussed from the viewpoint of the inter-relatedness of the sources.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bear HD (1986) Tumor-specific suppressor T-cells which inhibit thein vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens. Cancer Res 46: 1805

    Google Scholar 

  2. Berendt MJ, North RJ (1980) T-cell mediated suppression of antitumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med 151: 69

    Google Scholar 

  3. Brunda MJ, Herberman RB, Holden HT (1980) Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 124: 2628

    Google Scholar 

  4. Brunner CJ, Muscoplat CC (1981) Regulation of immune responses with prostaglandins. Adv Exp Med Biol 137: 243

    Google Scholar 

  5. Chow KN, Battisto JR (1988) Down-regulation of cytotoxic T-lymphocytes development by a minor stimulating locus-induced suppressor cascade that involves Lyt1+ T-cells IA− macrophages, and their factors. J Immunol 140: 1

    Google Scholar 

  6. Djeu JY, Jeffrey A, Heinbaugh HT, Herberman RB (1979) Augmentation of mouse natural killer cells activity by interferon and interferon inducers. J Immunol 122: 175

    Google Scholar 

  7. Dye ES (1986) The antimetastatic function of concomitant antitumor immunity: II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells. J Immunol 136: 1510

    Google Scholar 

  8. Dye ES (1986) The antimetastatic function of concomitant antitumor immunity: I. Host Lyt1+2+ effector T cells prevent the enumeration of metastatic tumor cells in a biological assay. J Immunol 136: 1504

    Google Scholar 

  9. Dye ES, North RJ (1981) T cell-mediated immunosuppression; an obstacle to adoptive immunotherapy of the p815 mastocytoma and its metastases. J Exp Med 154: 1033

    Google Scholar 

  10. Dye ES, North RJ (1984) Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors. J Leukocyte Biol 36: 27

    Google Scholar 

  11. Elgert KD, Farrar WL (1978) Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages. J Immunol 120: 1345

    Google Scholar 

  12. Fujii T, Iganrashi T, Kishimoto S (1987) Significance of suppressor macrophages for immunosurveillance of tumor bearing mice. J Natl Cancer Inst 78: 509

    Google Scholar 

  13. Garner RE, Malick AP, Elgert KD (1986) Variations in macrophage antigen phenotype: A correlation between Ia antigen reduction and immune dysfunction during tumor growth. J Leukocyte Biol 40: 561

    Google Scholar 

  14. Gemsa D, Leser HG, Deimann W, Resch K (1982) Suppression of T lymphocyte proliferation during lymphoma growth in mice: role of PGE2-producing suppressor macrophages. Immunobiology 161: 385

    Google Scholar 

  15. Gidlund M, Oen A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK activity in mice injected with interferon and interferon inducers. Nature 273: 759

    Google Scholar 

  16. Gregorian SK, Battisto JR (1990) Immunosuppression in murine renal cell carcinoma. I. Characterization of its extent and severity. Cancer Immunol Immunother 31: 325–334

    Google Scholar 

  17. Guillous PJ, Sedman PC, Ramsden CW (1989) Inhibition of lymphokine-activated killer cell generation by cultured tumor cell linesin vitro. Cancer Immunol Immunother 28: 43

    Google Scholar 

  18. Hellstrom KE, Hellstrom I, Kant JA, Tamerius JD (1978) Regression and inhibition of sarcoma growth by interference with a radiosensitive T cell population. J Exp Med 148: 799

    Google Scholar 

  19. Herberman RB, Ortaldo JR (1981) Natural killer cells: their role in defenses against diseases. Science 214: 24

    Google Scholar 

  20. Herberman RB, Nunn ME, Holden HT, Stall S, Djeu JY (1977) Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int J Cancer 19: 555

    Google Scholar 

  21. Huben RP, Connely R, Goldrosen MH, Murphy GP, Pontes EJ (1983) Immunotherapy of murine renal cancer. J Urol 129: 1075

    Google Scholar 

  22. Kadhim SA, Rees RC (1984) Enhancement of tumor growth in mice: Evidence for the involvement of host macrophages. Cell Immunol 87: 259

    Google Scholar 

  23. Lala PK, Santer V, Libenson H, Parhar RS (1985) Changes in the host natural killer population in mice during tumor development: I. Kinetics andin vivo significance. Cell Immunol 93: 250

    Google Scholar 

  24. Naor D (1979) Suppressor cells: permitters and promoters of malignancy. Adv Cancer Res 29: 45

    Google Scholar 

  25. North RJ (1985) Down-regulation of the anti-tumor immune response. Adv Cancer Res 45: 1

    Google Scholar 

  26. North RJ (1986) Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells. J Exp Med 164: 1652

    Google Scholar 

  27. North RJ, Bursuker I (1984) The generation and decay of the immune response to a progressive fibrosarcoma. I. Lyt1+2− suppressor T cells down-regulate the generation of Lyt1−2+ effector cells. J Exp Med 159: 1295

    Google Scholar 

  28. Parhar RS, Lala PK (1985) Changes in the host natural killer cell population in mice during tumor development: II. The mechanism of suppression of NK activity. Cell Immunol 93: 265

    Google Scholar 

  29. Pelus LM, Bockman RS (1979) Increased prostaglandin synthesis by macrophages from tumor-bearing mice. J Immunol 123: 2118

    Google Scholar 

  30. Salup RR, Herberman RB, Wiltrout RH (1985) Role of natural killer activity in development of spontaneous metastases in murine renal cancer. J Urol 134: 1236

    Google Scholar 

  31. Schatter S, Granstein RD, Drebin JA, Green MI (1984) Suppressor T cells and the immune response to tumors. CRS Crit Rev Immunol 4: 335

    Google Scholar 

  32. Sone S, Utsugi T, Nii A, Ogura T (1987) Effects of human alveolar macrophages on the induction of lymphokine (IL-2) activated killer cells. J Immunol 139: 29

    Google Scholar 

  33. Stuttman O (1975) Immunosuppression and malignancy. Adv Cancer Res 22: 261

    Google Scholar 

  34. Stuttman O, Figarella EG, Wisun R (1980) Natural cytotoxic “NC” cells in tumor-bearing mice. In: Herberman RB (ed) Natural cell-mediated immunity against tumors. Academic Press, NY, p 1073

    Google Scholar 

  35. Ting CC, Hargrove ME (1982) Tumor cell-triggered macrophagemediated suppression of the T cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression. J Natl Cancer Inst 69: 873

    Google Scholar 

  36. Ting CC, Rodrigues D (1980) Switching on the macrophage mediated suppressor mechanism by tumor cells to evade host immune surveillance. Proc Natl Acad Sci USA 77: 4265

    Google Scholar 

  37. Ting CC, Rodrigues D (1982) Tumor cell-triggered macrophagesmediated suppression of the T cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. J Natl Cancer Inst 69: 867

    Google Scholar 

  38. Ting CC, Rodrigues D, Ting RC, Wivel N, Collins MJ (1979) Suppression of T cell-mediated immunity by tumor cells: immunogenecity versus immunosuppression and preliminary characterization of the suppressive factors. Int J Cancer 24: 644

    Google Scholar 

  39. Ting CC, Hargrove ME, Stephany D (1987) Generation of activated killer cells in tumor-bearing hosts. Int J Cancer 39: 232

    Google Scholar 

  40. Treves AI, Cohen LR, Feldman M (1976) Suppressor factor secreted by T lymphocytes from tumor-bearing mice. J Natl Cancer Inst 57: 709

    Google Scholar 

  41. Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR (1984) Enhancing T lymphocytes from tumor-bearing mice. Eur J Immunol 4: 722

    Google Scholar 

  42. Webb DR, Nowowiejski I (1981) Control of suppressor cell activation via endogenous prostaglandin synthesis: the role of T cells and macrophage. Cell Immunol 63: 321

    Google Scholar 

  43. Wiltrout RH, Boyd MR, Back TC, Salup RP, Arthur JA, Hornung RL (1988) Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer. J Immunol 140: 3261

    Google Scholar 

  44. Yurochko AD, Nagarkatti PS, Nagarkatti M, Elgert KD (1989) Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells. Cancer Immunol Immunother 30: 170

    Google Scholar 

  45. Zoller M, Wigzell H (1982) Normally occurring inhibitory cells for natural killer cell activity: II. Characterization of the inhibitory cell. Cell. Immunol. 74: 27

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Cleveland State University, 44115, Cleveland, Ohio, USA

    Shahik K. Gregorian

  2. Section of Immunology and Cancer, The Research Institute, Cleveland Clinic Foundation, 44195-5048, Cleveland, Ohio, USA

    Jack R. Battisto

Authors
  1. Shahik K. Gregorian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jack R. Battisto
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Offered in partial fulfillment of the requirements for the Ph. D. degree at Cleveland State University by SKG.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gregorian, S.K., Battisto, J.R. Immunosuppression in murine renal cell carcinoma. Cancer Immunol Immunother 31, 335–341 (1990). https://doi.org/10.1007/BF01741404

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741404

Keywords

Search

Navigation